Cancer and Haematology

Denna sida på svenska

Karolinska Institutet is at the forefront of cancer research in the world. The primary goal of the research conducted at KI is to make sure that as few people as possible suffer or die from cancer. Its research encompasses all areas, from the examination of molecules to the study of large demographic groups.

Research on Cancer and Haematology
Research areas
Research groups

In depth articles and features

Tema barncancer

Spotlight on Childhood Cancer

These days, the lives of many children diagnosed with cancer can be saved. But the treatment can lead to problems later in life.
Professor Anna Martling. Foto: Martin Stenmark

Anna Martling: “When you meet the patient the circle closes”

Research breakthroughs are not just about new discoveries. Professor Anna Martling tells us how a long period spent on development meant that she was able to offer a patient life-saving treatment.
Bild på Henrik Druid

A tale of three researchers: With death as a colleague

In our society we do our best to keep death at bay. We have met three researchers who have chosen to work full-time with death.
anhoriga_webb.jpg

Spotlight on Close relatives of cancer patients

Close relatives of patients with serious illnesses such as cancer are at risk of becoming ill themselves as a result of the psychological strain.

Some of our professors in the area

Professor Sonia Lain

Searching for substances effective against tumour cells

Sonia Lain is searching for molecules that have the potential to become future cancer therapies. She is searching for substances that are effective against cancer cells but easier on healthy tissue.
Professor Sir David Lane

p53 – the guardian of the genome

Sir David Lane discovered the protein p53 at the end of the 1970s. The protein's role is to discover and prevent genetic mutations that can lead to cancer.
Professor Jiri Bartek. Foto: Ulf Sirborn

He wants to find the vulnerability in cancer

The continual division of cells in our bodies is pre-conditional to life; however, the process is a complex and delicate one and subject to serious error. 
Professor Oscar Fernandez-Capetillo. Foto: Ulf Sirborn

Research on replicative damage and ageing

Damage to our DNA is responsible for both cancer and ageing. But what causes the damage and what does the body do to neutralise it? 
Professor Anna Martling. Foto: Ulf Sirborn

Trying to alleviate severe side effects

Anna Martling's research is aimed at curing more patients with colorectal cancer and reducing the serious side effects of the treatment that many patients suffer.
Professor Bertrand Joseph. Foto: Ulf Sirborn

Mechanisms for life and death are related

Our bodies have systems for repairing damaged cells so that they survive, and systems for letting cells die. If these mechanisms dysfunction, disease ensues. 
Stig Linder

Targeting slowly dividing cells

Stig Linder's research aims to develop new cancer drugs. Two of his discoveries are currently undergoing phase 1 tests in the USA.

Strategic research programme in Cancer

The Strategic Research Programme in Cancer (StratCan) combines cancer biology with clinical oncology by bringing together top level cancer scientists from different disciplines. The overall goal is to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.

Centre for Advanced Cancer Therapies

The vision and goal to this centre is to generate scientific discoveries that can be rapidly translated into the clinic for the benefit of patients and society. The centre has a multidisciplinary approach that integrates clinical research with state of the art HTP screening of chemical libraries and target identification/validation technologies.

Center for Immune Modulatory Therapies for Autoimmunity and Cancer

The main focus of the centre is developing innovative immune-based treatment approaches and accelerating the movement of effective immunotherapies into the clinic as part of the standard of care for patients.

BRECT – Breast Cancer Theme Center

Translational Thematic Center that aims to increase our understanding of critical steps in breast cancer development and therapy. The research span from basic studies using cell lines, animal models and patient biopsies, to prospective clinical studies and clinical trials, with the ultimate goal to improve breast cancer therapy and disease outcome.

News about cancer and haematology

Title Post date
Test identifies breast cancer patients with very low risk of death 29 Jun 2017
The presence of the protein KIF1Bβ can play a central role for the outcome of a neuroblastoma diagnosis 26 Jun 2017
New possible target for cancer treatment 07 Jun 2017
NEWS 29 May 2017
Dissertation 16 June 2017: Donghao Lu 24 May 2017
RSS
Cancer and Oncology
13 Dec 2016 by Katarina Sternudd.